A Trial Comparing Qam With Qpm Dosing in Assisted Reproductive Technologies (ART)

Completed

• Conditions: Infertility

• Registration Number: NCT01139593
• Lead Sponsor: Virginia Center for Reproductive Medicine

Brief Summary

This is a prospective randomized trial comparing the outcome in women undergoing IVF/ICSI when taking their gonadotropin dosage in the morning (am) or evening (pm).

Detailed Description

Not available

Study Timeline

• Study Start: 2010-06
• Study First Submitted: 2010-06-06
• Study First Submitted QC: 2010-06-07
• Study First Posted: 2010-06-08
• Primary Completion: 2015-11
• Status Verified: 2015-12
• Study Completion: 2015-12
• Last Update Submitted: 2015-12-08
• Last Update Posted: 2015-12-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 128

Inclusion Criteria

• women between 21-42 undergoing IVF

Exclusion Criteria

• women > 45,
• women with one ovary,
• donor egg,
• surrogacy,
• FET cycles,
• uterine problems,
• large fibroids

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Live birth rate	4 years

Trial Locations

Locations (1)

Virginia Center for Reproductive Medicine; 🇺🇸 Reston, Virginia, United States